BeStock  
Markets › Compare › PVLA vs RCUS

PVLA vs RCUS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PVLA · Palvella Therapeutics$142.85 ▼ 2.00%
RCUS · Arcus Biosciences$15.62 ▼ 1.01%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6192123155186Nov 24, '25May 26, '26Nov 20, '26
  • PVLA +45.7%
  • RCUS -32.6%

Head to head

MetricPVLARCUS
Price$142.85$15.62
Change today▼ 2.00%▼ 1.01%
Market cap$2.09B$2.25B
Return, 3 months-2.0%-48.1%
Return, year to date+36.5%-34.5%
Return, 1 year+51.8%-29.2%
P/E (TTM)––
P/B10.66.3
P/E percentile vs own 5y27th46th
Dividend yield––
Revenue growth (YoY, latest qtr)–-65.4%
Net profit growth (YoY)-117.2%+5.2%
Gross margin––
Operating margin–-475.0%
Net margin–-453.0%
Return on equity-63.4%-114.1%
Analyst target vs. price+59.4%+166.6%
Analyst buy share100%83%
RSI (14)4629
30-day volatility70.1%83.2%
Max drawdown, 1 year-31.1%-50.5%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • RCUS is the largest of the group by market value.
  • PVLA has returned the most over the past year.
  • PVLA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top